Seaport Therapeutics, Inc.
SPTX · Pharmaceutical Preparations
Latest available SEC filing: SCHEDULE 13G ·
Latest disclosures
-
Form SCHEDULE 13G
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Hombach Robert J.: Form 4
Insider disclosure · Filed · Report period 22 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- SPTX · 81221K108 - Voting Common Stock, $0.001 par value per share
Company details and SEC sources
CIK 0002042347 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- SPTX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 6 Tide Street, Suite 400, Boston, MA, 02110
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields